意大利多中心登记研究:复杂腹主动脉及胸腹主动脉瘤开窗/分支腔内修复术的临床结局预测因素
结果显示围手术期死亡率为5%,脊髓缺血发生率为8%,随访期间生存率1年和3年分别为88%和78%。多种术前合并症和术后并发症与不良结局独立相关。
要点
- Crawford I-III型胸腹主动脉瘤和术后肾脏并发症是脊髓缺血的独立预测因素。
- 术前慢性肾功能衰竭、术后肠缺血、心脏并发症、脑血管并发症和脊髓缺血与30天/住院死亡率独立相关。
- 胸腹主动脉瘤、夹层后胸腹主动脉瘤和术后肠缺血是再干预的独立预测因素。
核心结论
- F/B-EVAR在意大利全国经验中显示出满意的中期结局。
- 应考虑多种风险因素以优化F/B-EVAR适应症和术后管理,降低并发症风险并改善中期结局。
研究设计与样本
- 纳入124例近肾腹主动脉瘤(21%)、121例肾周腹主动脉瘤(20%)和351例胸腹主动脉瘤(59%)。
- 择期手术520例(87%),急诊手术76例(13%)。
主要发现
- 术后心脏、肺和肾脏并发症分别发生在41例(7%)、50例(8%)和80例(13%)患者中。
- 32例(5%)发生围手术期死亡。
- 平均随访25±7个月,1年和3年免于靶内脏血管闭塞率分别为96%和93%,免于再干预率分别为92%和85%。
- 1年和3年生存率分别为88%和78%。
临床怎么用
- 对于复杂主动脉瘤患者,术前应评估慢性肾功能衰竭等风险因素以优化患者选择。
- 术后需密切监测并积极防治肾脏、心脏、脑血管并发症及肠缺血,以降低死亡和再干预风险。
- 胸腹主动脉瘤患者,尤其是夹层后胸腹主动脉瘤,应加强随访监测再干预。
局限性
- 回顾性分析设计可能存在选择偏倚和信息偏倚。
- 随访时间相对较短(平均25±7个月),可能不足以评估长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Complex aortic aneurysms (juxtarenal aortic aneurysms [JAAA], pararenal aortic aneurysms [PAAAs], thoracoabdominal aortic aneurysms TAAAs) are treated with increasing frequency through fenestrated and branched endovascular repair (F/B-EVAR); however, the outcome of these procedures is usually reported separately by single experiences and wider overviews are not frequent. The aim of this study was therefore to report an Italian experience analyzing the results obtained in four academic centers to evaluate the predictors of outcomes. METHODS: Between 2008 and 2019, all consecutive patients undergoing F/B-EVAR in four Italian university centers were recorded prospectively and analyzed retrospectively. Preoperative comorbidities and postoperative complications were classified according with the Society for Vascular Surgery reporting standard. Postoperative complications and 30-day/in-hospital mortality were assessed as early outcomes. Survival, freedom from reinterventions and target visceral vessels patency were assessed as follow-up outcomes by Kaplan-Meier analysis. Risk factors for 30-day/in-hospital mortality and spinal cord ischemia (SCI) were determined by multivariate analysis. Risk factors for follow-up mortality and reinterventions were evaluated by Cox regression model. RESULTS: Five hundred ninety-six patients underwent F/B-EVAR for 124 JAAAs (21%), 121 PAAAs (20%), and 351 TAAAs (59%). Elective and urgent procedures were performed in 520 (87%) and 76 (13%) cases, respectively. Postoperative cardiac, pulmonary, and renal complications were reported in 41 (7%), 50 (8%), and 80 (13%) patients, respectively. Seven bowel ischemia (1%) and 23 cerebrovascular complications (4%) occurred. Forty-seven (8%) patients suffered SCI with 17 cases (3%) of permanent paraplegia. Crawford's extent I-II-III TAAAs (odds ratio [OR], 13.41; 95% confidence interval [CI], 1.77-101.65; P = .012) and postoperative renal complications (OR, 3.84; 95% CI, 1.70-8.69; P = .001) independently predicted SCI. Thirty-two patients (5%) died in the perioperative period. Preoperative chronic renal failure (OR, 7.81; 95% CI, 7.81-26.31; P = .001), postoperative bowel ischemia (OR, 26.97; 95% CI, 3.37-215.5; P = .002), cardiac complications (OR, 5.77; 95% CI, 1.41-23.64; P ≤ .001), cerebrovascular complications (OR, 28.63; 95% CI, 5.20-157.5; P < .001), and SCI (OR, 5.99; 95% CI, 1.12-32.5; P = .036) were independently correlated with 30-day/in-hospital mortality. The mean follow-up was 25 ± 7 months. Freedom from target visceral vessels occlusion and freedom from reintervention were 96% and 92% at 1 year and 93% and 85% at 3 years, respectively. TAAAs (hazard ratio [HR]. 3.16; 95% CI, 1.68-5.92; P ≤ .001), postdissection TAAAs (HR, 2.20; 95% CI, 1.30-4.90; P = .05) and postoperative bowel ischemia (HR, 11.98; 95% CI, 1.53-93.31; P = .018) were independent predictors of reinterventions. Survival was 88% and 78% at 1 and 3 years, respectively. Preoperative chronic renal failure (HR, 2.39; 95% CI, 1.59-3.59; P ≤ .001), urgent repair (HR, 1.80; 95% CI, 1.03-3.20; P = .039), TAAAs (HR, 2.01; 95% CI, 1.13-3.56; P = .017), postoperative bowel ischemia (HR, 5.55; 95% CI, 2.11-14.59; P = .001), cardiac complications (HR, 3.89; 95% CI, 2.25-6.71; P ≤ .001), and pulmonary complications (HR, 1.97; 95% CI, 1.56-3.35; P = .013) were independent predictors of mortality during follow-up. CONCLUSIONS: F/B-EVAR is associated with satisfactory midterm outcomes in a nationwide experience. A variety of risk factors should be considered in F/B-EVAR indications and postoperative patient management to decrease the risk of postoperative complications and improve midterm outcomes.
引用
- Gallitto E, Faggioli G, Melissano G, et al. Preoperative and postoperative predictors of clinical outcome of fenestrated and branched endovascular repair for complex abdominal and thoracoabdominal aortic aneurysms in an Italian multicenter registry. J Vasc Surg. 2021. PMID: 34098004. doi:10.1016/j.jvs.2021.04.072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。